| Product Code: ETC12772926 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Non-Small Cell Lung Cancer Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Non-Small Cell Lung Cancer Market - Industry Life Cycle |
3.4 Austria Non-Small Cell Lung Cancer Market - Porter's Five Forces |
3.5 Austria Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Austria Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Austria Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Austria Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Austria Non-Small Cell Lung Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Austria |
4.2.2 Advancements in treatment options for non-small cell lung cancer |
4.2.3 Growing awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 High cost associated with novel treatment options |
4.3.2 Limited accessibility to specialized healthcare facilities in certain regions of Austria |
5 Austria Non-Small Cell Lung Cancer Market Trends |
6 Austria Non-Small Cell Lung Cancer Market, By Types |
6.1 Austria Non-Small Cell Lung Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021 - 2031F |
6.1.5 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031F |
6.1.6 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Austria Non-Small Cell Lung Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 Austria Non-Small Cell Lung Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4 Austria Non-Small Cell Lung Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.4.3 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Tumor Management, 2021 - 2031F |
6.4.4 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4.5 Austria Non-Small Cell Lung Cancer Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
7 Austria Non-Small Cell Lung Cancer Market Import-Export Trade Statistics |
7.1 Austria Non-Small Cell Lung Cancer Market Export to Major Countries |
7.2 Austria Non-Small Cell Lung Cancer Market Imports from Major Countries |
8 Austria Non-Small Cell Lung Cancer Market Key Performance Indicators |
8.1 Average age of diagnosis for non-small cell lung cancer patients in Austria |
8.2 Percentage of non-small cell lung cancer cases detected at early stages |
8.3 Adoption rate of innovative treatment modalities in the Austrian healthcare system |
9 Austria Non-Small Cell Lung Cancer Market - Opportunity Assessment |
9.1 Austria Non-Small Cell Lung Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Austria Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Austria Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Austria Non-Small Cell Lung Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Austria Non-Small Cell Lung Cancer Market - Competitive Landscape |
10.1 Austria Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024 |
10.2 Austria Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here